Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Open Access
- 28 August 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (35), 23502-23516
- https://doi.org/10.1074/jbc.m109.012393
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Diltiazem, a L-type Ca2+ channel blocker, also acts as a pharmacological chaperone in Gaucher patient cellsMolecular Genetics and Metabolism, 2009
- Identification of Pharmacological Chaperones for Gaucher Disease and Characterization of Their Effects on β‐Glucocerebrosidase by Hydrogen/Deuterium Exchange Mass SpectrometryChemBioChem, 2008
- Isofagomine Induced Stabilization of GlucocerebrosidaseChemBioChem, 2008
- The Spectrum of Parkinsonian Manifestations Associated With Glucocerebrosidase MutationsArchives of Neurology, 2008
- Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: Therapeutic implications for amyotrophic lateral sclerosisExperimental Neurology, 2008
- Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosisMolecular Genetics and Metabolism, 2008
- Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's diseaseNeurobiology of Disease, 2008
- Isofagomine increases lysosomal delivery of exogenous glucocerebrosidaseBiochemical and Biophysical Research Communications, 2008
- High-Throughput Screening for Human Lysosomal β-N-Acetyl Hexosaminidase Inhibitors Acting as Pharmacological ChaperonesCell Chemical Biology, 2007
- Isofagomine- and 2,5-Anhydro-2,5-imino-d-glucitol-Based Glucocerebrosidase Pharmacological Chaperones for Gaucher Disease InterventionJournal of Medicinal Chemistry, 2006